Immunology and Microbiology
B Cell
100%
T Cell
62%
Antineoplastic Activity
56%
Protein Tertiary Structure
43%
Thrombocyte Activating Factor
43%
T Cell Receptor
43%
Plasmid
43%
Antigen Specificity
43%
Cell Expansion
43%
Lentivirus Vector
43%
CXCR5
43%
Chimeric Antigen Receptor T-Cell
43%
Histone Acetylation
43%
MHC Class I
43%
Cytotoxic T-Cell
43%
Chimeric Antigen Receptor
25%
CD19
25%
Virus
21%
Restriction Enzyme
21%
Monoclonal Antibody
18%
Chimeric Antigen Receptor T-Cell Therapy
18%
Cell Line
18%
Xenograft
18%
Promoter Region
15%
Mast Cell
13%
Antigen-Presenting Cell
12%
Lymphoma Cell Line
12%
Cell Differentiation
12%
Cytotoxicity
12%
Reporter Gene
10%
Immunity
8%
Cell Migration
8%
CXCR4
8%
Hybridoma
6%
Gene Expression Assay
6%
Epitope
6%
Cell Surface
6%
Peptides
6%
Lymphoid Organ
6%
CD3 Antigen
6%
Cytokine
6%
Cell Antigen
6%
Single-Chain Variable Fragment
6%
Downregulation
6%
T Cell Subset
6%
RNA Sequencing
6%
Tumor Antigen
6%
Peripheral Blood Mononuclear Cell
6%
CD8
6%
Tonsil
6%
Medicine and Dentistry
Antineoplastic Activity
61%
Cytotoxic T-Cell
43%
Histone Acetylation
43%
Platelet-Activating Factor
43%
B-Cell Lymphoma
43%
P21
43%
Chimeric Antigen Receptor T-Cell
43%
Chimeric Antigen Receptor
34%
B Cell
32%
Chimeric Antigen Receptor T-Cell Immunotherapy
26%
In Vitro
26%
Monoclonal Antibody
26%
Xenograft
26%
Cell Line
26%
T Cell
24%
Follicular Lymphoma
21%
Neoplasm
17%
Knock Out
17%
Lymphoma Cell Line
17%
Cytotoxicity
16%
Cell Differentiation
14%
Mast Cell
13%
CD3 Antigen
8%
Cytokine
8%
Cell Surface Protein
8%
Cell Antigen
8%
Cancer
8%
Hybridoma
8%
Downregulation
8%
Immunosuppressive Treatment
8%
Aggressive Lymphoma
8%
Cell Migration
8%
Single Chain Fragment Variable Antibody
8%
Clinical Trial
8%
CD8 Antigen
8%
T Cell Subset
7%
Follicle
7%
Tail Suspension Test
7%
Mitochondrial Transcription Factor A
7%
Tonsil
7%
Lymphoid Organ
7%
Ex Vivo
7%
Adoptive Transfer
7%
RNA Sequencing
7%
Gene Expression Profiling
7%
Keyphrases
Multimodal MRI
43%
MitoPark Mouse
43%
Chimeric Antigen Receptor T Cells (CAR-T)
43%
CXCR5+CD8+ T Cells
43%
B-cell Lymphoma
43%
CD79B
43%
Histone Acetylation
43%
Platelet-activating Factor
43%
Construction System
43%
Induced Expression
43%
Ultraviolet-induced
13%
Mast Cells
13%
Chimeric Antigen Receptor T-cell Therapy
9%
Monoclonal Antibody
9%
Lymphoma
9%
Immune Suppression
8%
CMV-specific T Cells
8%
Cell Migration
8%
Lymphoma Cells
6%
Tumor
6%
Co-stimulatory Domain
6%
Cell Therapy Product
6%
CD19
6%
Antitumor Activity
6%
Receptor Molecules
6%
CNS Drug Delivery
5%
Head Protection
5%
Water Plasma
5%